JMIRx Med

JMIRx Med 由 JMIR Publications 出版。按 OpenAlex 近年发文统计，该刊主要发表 COVID-19 epidemiological studies、COVID-19 Clinical Research Studies、SARS-CoV-2 and COVID-19 Research 等主题的论文，这 3 个主题约占 27.3%。（根据 OpenAlex 主题统计与中科院分区数据生成）

JMIRx Med (ISSN 2563-6316), which has been accepted for indexing in PubMed and PubMed Central, is an innovative overlay journal to MedRxiv and JMIR Preprints (other preprint servers are invited to join). JMIRx peer-reviews preprints and publishes their revised "version of record" with peer-review reports across a broad range of medical, clinical and related health sciences. Unlike the majority of JMIR journals, papers published in this journal do not require a digital health focus - in fact, most papers we published in the first months of the journal were related to COVID19, but we publish all research that qualifies for preprinting on MedRxiv. Conceived to address the urgent need to make highly relevant scientific information available as early as possible without losing the quality of the peer-reviewed process, this innovative new journal is the first in a new series of “superjournals”. Superjournals (a type of "overlay" journal) sit on top of preprint servers (JMIRx-Med serves MedRxiv and JMIR Preprints), offering peer-review and everything else a traditional scholarly journal does. Our goal is to rapidly peer review and publish a paper. All JMIRx Med papers must have originated as a preprint. All JMIRx Med papers are rigorously peer-reviewed, copyedited and XML-tagged. Accepted papers are published along with the related Peer Review Reports and Author Responses to Peer Review Reports, providing an additional layer of transparency to the scholarly publishing process. To submit a preprint to JMIRx, either submit a Preprint directly to JMIRx (and opt-in when you are asked to expose the submission on JMIR Preprints) or upload a Preprint to MedRxiv and then user the M2J (or here called M2JMIR) functionality at MedRxiv to submit the paper to the Journal of Medical Internet Research - you will then receive an email with a link to the JMIR submission form, where you must change the target journal to JMIRx. For more information please consult our Knowledge Base article "What is JMIRx?" Need help choosing a journal? Use our Journal Finder tool to find the perfect match for your manuscript. Get Started

摘自期刊官网 Aims & Scope

主编 Fuqing Wu出版商官网

编委会国家分布：未见中国大陆编委；主要国家 美国 5、中国台湾 1、泰国 1（共 7 位编委标注了国家） 编委会 ↗出版商官网 · 2026-11-02

中科院期刊分区表

数据库收录

DOAJLetPub

国际期刊预警名单：各版本均未列入LetPub

期刊官网自述收录

PMCPubMed出版商官网

期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

h-index

22OpenAlex · 2026-11-01

i10-index

66OpenAlex · 2026-11-01

两年平均被引

3.24OpenAlex · 2026-11-01

Gold OA 文章占比

0%LetPub · 2026-11-01

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

16 WeeksLetPub · 2026-11-01

投稿到发表（期刊自报）

约 35 周DOAJ · 2026-11-01

评审方式

单盲同行评审DOAJ

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

JMIR Publications

出版国家或地区

Canada

出版语言

English

ISSN

2563-6316

官方链接

• 期刊主页 ↗LetPub
• 作者指南 ↗LetPub
• Aims & Scope ↗LetPub
• APC 费用说明 ↗DOAJ
• 费用减免政策 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ
• 评审流程 ↗LetPub
• 编委会 ↗LetPub